Every record from PeptideMeter · page 8
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042711 | Melanotan II | GGPeps | GGPE-2509-H8939 | 2026-Q1 | 98.39 | 5.47 | 93.9 | Laboratory-retained | 1 | FAIL |
| AX-2026-042709 | Melanotan II | GGPeps | GGPE-2509-H8939 | 2026-Q1 | 99.41 | 6.06 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041513 | Enclomiphene citrate | QYB | QYB-2603-A6476 | 2026-Q1 | 99.56 | 4.68 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041234 | Retatrutide | WWB | WWB-2510-H1662 | 2026-Q1 | 99.82 | 4.90 | 104.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042875 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 99.81 | 4.37 | 93.3 | Supplier-supplied | 0 | FAIL |
| AX-2026-042526 | PEG-MGF | ERP | ERP-2509-K6500 | 2026-Q1 | 98.36 | 4.87 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042315 | Tirzepatide | HJ | HJ-2508-P3416 | 2026-Q1 | 98.54 | 4.03 | 107.0 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042013 | 5-Amino-1MQ | TFC | TFC-2508-L6321 | 2026-Q1 | 99.90 | 5.78 | 90.3 | Supplier-supplied | 0 | FAIL |
| AX-2026-041680 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.51 | 6.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042949 | Ipamorelin | KP | KP-2512-X4190 | 2026-Q1 | 98.31 | 2.24 | 103.0 | Buyer-sourced | 2 | FAIL |
| AX-2026-042921 | Semaglutide | MKM | MKM-2508-R2718 | 2026-Q1 | 98.27 | 5.36 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041507 | Enclomiphene citrate | QYB | QYB-2603-A6476 | 2026-Q1 | 99.15 | 4.46 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041281 | Tirzepatide | WWB | WWB-2601-J2662 | 2026-Q1 | 99.35 | 6.53 | 103.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042612 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 97.98 | 7.25 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043360 | BPC-157 | CPC | CPC-2510-R2456 | 2026-Q1 | 98.75 | 8.13 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041422 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.77 | 4.83 | 93.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042894 | Semaglutide | MKM | MKM-2510-S2813 | 2026-Q1 | 98.48 | 6.12 | 98.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043565 | Tirzepatide | BCH | BCH-2601-N7656 | 2026-Q1 | 97.76 | 3.95 | 95.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041966 | KPV | TFC | TFC-2508-M4888 | 2026-Q1 | 99.35 | 2.83 | 91.6 | Supplier-supplied | 0 | FAIL |
| AX-2026-041407 | PT-141 (Bremelanotide) | WWB | WWB-2509-A4716 | 2026-Q1 | 99.93 | 5.02 | 88.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042736 | Tirzepatide | GGPeps | GGPE-2510-L9923 | 2026-Q1 | 98.05 | 4.18 | 99.4 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042075 | BPC-157 | TFC | TFC-2512-L7022 | 2026-Q1 | 98.93 | 6.01 | 107.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043550 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 97.71 | 3.58 | 98.3 | Buyer-sourced | 1 | FAIL |
| AX-2026-041718 | BPC-157 | QSC | QSC-2510-J9685 | 2026-Q1 | 99.62 | 5.26 | 104.8 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043547 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.33 | 3.67 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042886 | CJC-1295 with DAC | MKM | MKM-2602-M1973 | 2026-Q1 | 98.87 | 3.56 | 97.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041681 | Ipamorelin | QSC | QSC-2602-W8804 | 2026-Q1 | 99.77 | 6.47 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041643 | Selank | QSC | QSC-2601-N8430 | 2026-Q1 | 99.90 | 6.68 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041758 | Selank | FGP | FGP-2511-D1094 | 2026-Q1 | 99.93 | 7.11 | 92.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042179 | ARA-290 | Homopeptide | HOMO-2602-K9510 | 2026-Q1 | 99.74 | 4.19 | 103.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042139 | Semax | Homopeptide | HOMO-2601-D8205 | 2026-Q1 | 99.93 | 7.16 | 90.3 | Supplier-supplied | 0 | PASS |
| AX-2026-041314 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.45 | 4.87 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042378 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 98.63 | 4.25 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042377 | Tirzepatide | SWB | SWB-2601-V4383 | 2026-Q1 | 99.28 | 4.18 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043558 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 97.63 | 3.64 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043189 | Exenatide | GL Biochem | GLBI-2509-A8203 | 2026-Q1 | 98.89 | 3.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041339 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.52 | 6.24 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042604 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.49 | 6.71 | 100.6 | Supplier-supplied | 1 | FAIL |
| AX-2026-042355 | TB-500 | HJ | HJ-2601-H3602 | 2026-Q1 | 99.93 | 6.10 | 107.3 | Supplier-supplied | 0 | PASS |
| AX-2026-042340 | GHRP-2 | HJ | HJ-2512-X3528 | 2026-Q1 | 99.58 | 3.90 | — | Supplier-supplied | 1 | MARGINAL |